Executive Chair Mark Simari said 2026 marked a turning point for the company, with the improved financial performance and manufacturing investment positioning IDT for its next stage of growth. …
IDT Australia targets profitability after reporting sharply narrowing loss
August 21, 2026 Latest NewsBioPharma
Latest Video
New Stories
-
IDT Australia targets profitability after reporting sharply narrowing loss
August 21, 2026 - - Latest News -
Opportunity #5 - From the hardest thing to secure to the easiest thing to get right
August 21, 2026 - - Latest News -
Biogen bolsters leadership ranks as it sharpens focus on patient access and innovation
August 21, 2026 - - Latest News -
Advent moves to acquire majority stake in NZCR Group
August 21, 2026 - -
Personalised mRNA cancer therapy clears Phase 3 milestone in resected melanoma
August 21, 2026 - - Latest News -
New Zealand researchers honoured for work tackling superbugs and blood cancer
August 20, 2026 - - Latest News -
Recce advances pivotal diabetic foot infection trial with active antibiotic comparator arm
August 20, 2026 - - Latest News